Somatic Mutations in Childhood Cancer Survivors
Author Information
Author(s): M. Hewitt, M.G. Mott
Primary Institution: Royal Hospital for Sick Children, Bristol
Hypothesis
Does chemotherapy and radiotherapy increase the frequency of somatic mutations in children treated for malignancies?
Conclusion
Children who received chemotherapy and radiotherapy show a significant increase in somatic mutations long after treatment.
Supporting Evidence
- Control children had mean variant frequencies of 9.5 and 5.8 x 10^6 erythrocytes.
- Patients showed significant elevation of both N0 and NN variants over 10 years from the end of treatment.
- The GPA assay requires small blood samples and provides rapid results.
Takeaway
This study found that kids who had cancer treatment have more mutations in their blood cells, which might mean they could get other cancers later.
Methodology
The study used a somatic cell mutation assay to assess variant erythrocytes in children before and after treatment.
Potential Biases
There may be bias due to age differences between control and treatment groups.
Limitations
The study had a small sample size and a heterogeneous group of malignancies.
Participant Demographics
Participants included 56 children with various malignancies, aged from 0.93 to 32.9 years.
Statistical Information
P-Value
0.01
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website